Skip to main content

TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS

Project description

Predictive biomarkers of therapy response in colorectal cancer

Colorectal cancer starts in the colon or rectum and usually develops over time from precancerous polyps. Standard of treatment for locally advanced rectal cancer (LARC) involves neoadjuvant chemoradiotherapy (nCRT) followed by surgical resection of the tumour. However, clinical response to nCRT varies from complete clinical response to a lack of response. The mission of the EU-funded STEPUPIORS project is to identify prognostic and predictive biomarkers in LARC by analysing the molecular profile of patients at diagnosis and during treatment. Given that colorectal cancer is the third most common malignancy worldwide, the results aim to support evidence-based patient selection and modification of current treatment protocols, thus minimising adverse effects and overall treatment cost, and improving patients' quality of life.

Coordinator

INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE
Net EU contribution
€ 750 000,00
Address
14 Pasterova St.
11000 Belgrade
Serbia

See on map

Region
Србија - север Београдски регион Београдска област
Activity type
Other
Other funding
€ 0,00

Participants (4)

IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Greece
Net EU contribution
€ 250 000,00
Address
Soranou Efesiou 4
115 27 Athina

See on map

Region
Κεντρικός Τομέας Αθηνών Aττική Αττική
Activity type
Research Organisations
Other funding
€ 0,00
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain
Net EU contribution
€ 243 601,25
Address
Calle Rossello 149 Puerta Bjs
08036 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Other
Other funding
€ 0,00
Third-party

Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.

HOSPITAL CLINIC DE BARCELONA
Spain
Net EU contribution
€ 6 398,75
Address
Calle Villarroel 170
08036 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Research Organisations
Other funding
€ 0,00
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
Netherlands
Net EU contribution
€ 250 000,00
Address
Plesmanlaan 121
1066 CX Amsterdam

See on map

Region
West-Nederland Noord-Holland Groot-Amsterdam
Activity type
Research Organisations
Other funding
€ 0,00